Listed
SME IPO
ACCRETIONNUTRAVEDA
Accretion Nutraveda
Accretion Nutraveda IPO ke live GMP, listing timeline, price band, subscription momentum aur key issue details yahan track karein.
IPO Details
Complete IPO information
| Current GMP |
₹62 |
| Estimated Listing Gain |
+48.06% |
| Price Band |
₹122.00 - ₹129.00 |
| Issue Price |
₹129.00 |
| Listing Price |
₹191.00 |
| Lot Size |
1,000 Shares |
| Issue Type |
SME |
| Issue Size |
TBA |
| Registrar |
TBA |
| Exchange |
NSE, BSE |
| Retail Quota |
TBA |
| Overall Subscription |
TBA |
| Listing Date |
04 Feb 2026 |
| Minimum Investment |
₹2,58,000 |
Timeline
IPO roadmap at a glance
01
Bidding Opens
28 Jan 2026
02
Bidding Closes
30 Jan 2026
Grey Market Premium
Daily GMP status
| Date |
GMP |
Change |
Gain |
| 04 Feb 2026 |
₹69.00 |
+₹53.00
|
53.49% |
| 03 Feb 2026 |
₹16.00 |
+₹10.00
|
12.40% |
| 02 Feb 2026 |
₹6.00 |
-
|
4.65% |
Market Lot
Application size breakdown
| Category |
Lots |
Shares |
Amount |
| Retail Minimum |
2 Lot |
2,000 |
₹2,58,000 |
| Retail Maximum |
2 Lot |
2,000 |
₹2,58,000 |
| S-HNI Minimum |
3 Lot |
3,000 |
₹3,87,000 |
| S-HNI Maximum |
7 Lot |
7,000 |
₹9,03,000 |
| B-HNI Minimum |
8 Lot |
8,000 |
₹10,32,000 |
Analysis
Accretion Nutraveda IPO – Key Details
| IPO Open Date |
January 27, 2026 |
| IPO Close Date |
January 30, 2026 |
| Face Value |
₹10 per Equity Share |
| Price Band |
₹122 – ₹129 per Share |
| Issue Size |
Approx ₹24.77 Crores |
| Fresh Issue |
Approx ₹24.77 Crores |
| Issue Type |
Book Build Issue |
| IPO Listing |
BSE SME |
Analysis
Accretion Nutraveda IPO – Market Lot Details
| Application |
Lot Size |
Shares |
Amount (₹) |
| Retail Minimum |
2 |
2,000 |
2,58,000 |
| Retail Maximum |
2 |
2,000 |
2,58,000 |
| S‑HNI Minimum |
3 |
3,000 |
3,87,000 |
| S‑HNI Maximum |
7 |
7,000 |
9,03,000 |
| B‑HNI Minimum |
8 |
8,000 |
10,32,000 |
Analysis
Accretion Nutraveda IPO – Reservation Details
| Investor Category |
Shares Offered |
Percentage (%) |
| Anchor Investors |
– |
– |
| QIB (Ex‑Anchor) |
9,08,000 |
47.29% |
| NII |
2,76,000 |
14.37% |
| Retail |
6,40,000 |
33.33% |
Analysis
Accretion Nutraveda IPO – Anchor Investors
| Anchor Bidding Date |
January 2026 |
| Anchor Investors List |
– |
| Shares Offered to Anchor Investors |
– |
| Anchor Size |
– |
| Lock‑in Period (50% – 30 Days) |
2026 |
| Lock‑in Period (50% – 90 Days) |
2026 |
Analysis
Accretion Nutraveda IPO – Important Dates
| IPO Open Date |
January 27, 2026 |
| IPO Close Date |
January 30, 2026 |
| Basis of Allotment |
February 2, 2026 |
| Refunds Initiation |
February 3, 2026 |
| Credit to Demat Account |
February 3, 2026 |
| IPO Listing Date |
February 4, 2026 |
| IPO Bidding Cut‑off Time |
January 30, 2026 – 5:00 PM |
Analysis
Accretion Nutraveda IPO – Promoters & Holding Pattern
Promoters: Mr. Mayur Popatlal Sojitra, Mr. Ankurkumar Shantilal Patel, Mr. Paraskumar Vinubhai Parmar, Mr. Hardik Mukundbhai Prajapati, Mr. Harshad Nanubhai Rathod & Mr. Vivek Ashok Kumar Patel
| Particulars |
Shares |
Shareholding (%) |
| Promoter Holding (Pre‑Issue) |
53,20,000 |
100.00% |
| Promoter Holding (Post‑Issue) |
72,40,000 |
73.48% |
Analysis
Accretion Nutraveda IPO – Objects of the Issue & Utilisation of Proceeds
| Purpose |
Amount (₹ Cr) |
| Purchase of machineries for automation in existing manufacturing unit |
4.22 |
| Purchase of machineries for new manufacturing setup |
8.03 |
| Funding working capital requirements of the company |
5.50 |
| General Corporate Purpose |
– |
Analysis
About Accretion Nutraveda IPO
Accretion Nutraveda, since its incorporation in 2021, has been focused on the manufacturing of Ayurvedic and Nutraceutical products in India. It offers Ayurvedic and Nutraceutical products in various dosages and forms, like tablets, capsules, oral liquids, powders, oils, and external preparations like balms, creams, and gels.
The company serves its customers in India as well as in international countries like Sri Lanka, Singapore, and the USA. The firm blends Ayurvedic and science to offer treatments for various areas, like liver care, women’s health, bone and joint health, cognitive support, and respiratory wellness. The company runs a 10,763 sq. ft. manufacturing facility situated in Gujarat. Its unit includes modern infrastructure and quality control systems.
Analysis
Accretion Nutraveda IPO – Company Financial Report
| Period Ended |
Revenue (₹ Cr) |
Expense (₹ Cr) |
PAT (₹ Cr) |
Assets (₹ Cr) |
| FY 2023 |
3.07 |
2.78 |
0.28 |
4.06 |
| FY 2024 |
5.20 |
4.28 |
0.82 |
4.64 |
| FY 2025 |
16.06 |
12.87 |
2.61 |
10.86 |
Analysis
Accretion Nutraveda IPO – Valuation (FY2025)
| KPI |
Values |
| ROE |
81.22% |
| ROCE |
36.98% |
| EBITDA Margin |
22.79% |
| PAT Margin |
16.33% |
| Debt to Equity Ratio |
– |
| Earning Per Share (EPS) |
₹7.19 (Basic) |
| Price / Earnings (P/E) |
N/A |
| Return on Net Worth (RoNW) |
48.85% |
| Net Asset Value (NAV) |
₹14.72 |
Analysis
Accretion Nutraveda IPO – Peer Group Comparison
| Company |
EPS (₹) |
P/E Ratio |
RoNW (%) |
NAV (₹) |
Income (₹ Cr) |
| Walpar Nutritions Ltd. |
1.80 |
23.94 |
11.27% |
13.65 |
60.26 |
| Influx Healthtech Limited |
7.31 |
25.93 |
36.72% |
5.31 |
104.99 |
Analysis
IPO Lead Managers aka Merchant Bankers
- Sobhagya Capital Options Pvt. Ltd.
